CTRI/2019/07/020173
Completed
Phase 1
Acute Evaluation of a Novel Leadless Pacemaker System
CALYAN CARDIAC THERAPEUTICS INDIA PVT LTD0 sites5 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Health Condition 1: I259- Chronic ischemic heart disease, unspecified
- Sponsor
- CALYAN CARDIAC THERAPEUTICS INDIA PVT LTD
- Enrollment
- 5
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Scheduled to undergo a non\-emergency open heart surgical procedure.
- •2\.Willing and capable of providing informed consent
Exclusion Criteria
- •1\.Patients who are not anatomically suitable to receive a sub\-xiphoidal implant
- •2\.Patients who have previously undergone an open heart surgical procedure
- •3\.Currently implanted with a cardiac pacemaker, implantable cardioverter defibrillator, or cardiac resynchronization device
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The LEADLESS Observational StudyIndications for VVI(R) PacemakerNCT02051972Abbott Medical Devices491
Not yet recruiting
Not Applicable
Chronic Evaluation of Novel Pacemaker SystemVentricular Pacing With Rate ResponseBradycardiaNCT06056817Calyan Technologies10
Recruiting
Not Applicable
Impact of the leadless pacemaker position on paced QRS morphology and prognosis: 3 dimensional analysis with cardiac computed tomography (MICRA-CT registry)Sick sinus syndromecomplete atrioventricular blockatrial fibrillation with bradycardiaJPRN-UMIN000035117Osaka Police Hospital50
Completed
Not Applicable
Performance of a new preloaded fiducial needle for guided radiation therapy of upper gastrointestinal cancersGastrointestinal CancersACTRN12618000246280Royal Adelaide Hospital55
Not yet recruiting
Not Applicable
Evaluation of the PulseCath, a Pulsatile Catheter Pump, in patients who need cardiac assist.cardiogenic shockheart failure10019280NL-OMON33512PulseCath BV20